Pranay Sinha, MD

Assistant Professor, Medicine

Pranay Sinha
617.638.7578
801 Massachusetts Ave

Biography

Dr. Sinha attended the University of Virginia School of Medicine and finished residency training at Yale-New Haven Hospital where he received a distinction in Global Health and Equity. He has been involved in TB research since 2014 and his primary interest is in the relationship between undernutrition and TB. Through epidemiological studies & health economic modeling, he hopes find ways to use nutritional policy to end TB. Dr. Sinha has field experience in India and South Africa. Clinically, he works as an Infectious Diseases physician at Boston Medical Center.

Education

  • University of Virginia School of Medicine, MD
  • Adelphi University, BS

Classes Taught

Publications

  • Published on 10/5/2023

    Acuña-Villaorduña C, Sinha P. Bedaquiline, Pretomanid, and Linezolid for Multidrug-Resistant Tuberculosis Treatment in the United States: A BIG Deal. Clin Infect Dis. 2023 Oct 05; 77(7):1063-1064. PMID: 37249072.

    Read at: PubMed
  • Published on 8/8/2023

    Sinha P, Mehta S. Food: the tuberculosis vaccine we already have. Lancet. 2023 Aug 19; 402(10402):588-590. PMID: 37567199.

    Read at: PubMed
  • Published on 6/14/2023

    Barathi A, Krishnamoorthy Y, Sinha P, Horsburgh C, Hochberg N, Johnson E, Salgame P, Govindarajan S, Senbagavalli PB, Lakshinarayanan S, Roy G, Ellner J, Sarkar S. Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis. J Public Health (Oxf). 2023 Jun 14; 45(2):304-311. PMID: 35692180.

    Read at: PubMed
  • Published on 4/17/2023

    Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis. 2023 Apr 17; 76(8):1483-1491. PMID: 36424864.

    Read at: PubMed
  • Published on 4/3/2023

    Sinha P, Jacobson KR, Horsburgh CR, Acuña-Villaorduña C. At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States. Open Forum Infect Dis. 2023 Apr; 10(4):ofad177. PMID: 37125228.

    Read at: PubMed
  • Published on 3/22/2023

    McLaughlin A, Burns R, Ryan M, Abbasi W, Harvey L, Hicks J, Sinha P, Assoumou SA. Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study. Subst Abuse. 2023; 17:11782218231160014. PMID: 36968974.

    Read at: PubMed
  • Published on 3/22/2023

    McLaughlin A, Burns R, Ryan M, Abbasi W, Harvey L, Hicks J, Sinha P, Assoumou SA. Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study. Subst Abuse. 2023; 17:11782218231160014. PMID: 36968974.

    Read at: PubMed
  • Published on 3/1/2023

    McQuaid CF, Sinha P, Bhargava M, Weerasuriya C, Houben RMGJ, Bhargava A. Tuberculosis and nutrition: what gets measured gets managed. Lancet Respir Med. 2023 Apr; 11(4):308-310. PMID: 36870352.

    Read at: PubMed
  • Published on 1/1/2023

    Carwile M, Cintron C, Jain K, Buonomo G, Oliver M, Dauphinais M, Narasimhan PB, Prakash Babu S, Sarkar S, Locks L, Kulatilaka N, Hochberg N, Lakshminarayanan S, Sinha P. Not business as usual: Engaging the corporate sector in India's TB elimination efforts. Glob Public Health. 2023 Jan; 18(1):2120405. PMID: 37252903.

    Read at: PubMed
  • Published on 10/20/2022

    VanValkenburg A, Kaipilyawar V, Sarkar S, Lakshminarayanan S, Cintron C, Babu SP, Knudsen S, Joseph NM, Horsburgh CR, Sinha P, Ellner JJ, Narasimhan PB, Johnson WE, Hochberg NS, Salgame P. Corrigendum: Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis. Front Immunol. 2022; 13:1064883. PMID: 36341454.

    Read at: PubMed

View 27 more publications: View full profile at BUMC

View all profiles